The Department of Pharmaceuticals (DoP) has extended the date of receipt of applications till March-end for the vacant slots under the Production-Linked Incentive (PLI) scheme for the promotion of domestic manufacturing of bulk drugs, an official release said on Monday.
The government has launched the PLI scheme to encourage domestic production of critical key starting materials (KSMs)/ drug intermediates and active pharmaceutical ingredients.
The DoP had issued notice on January 27 inviting applications for vacant slots (10 APIs) under the PLI scheme for bulk drug and the last date of application was March 13, 2022. "Based on the representation received from the industries/associations, the DoP has decided to extend the timeline for filling of application up to March 31, 2022," the Ministry of Chemicals and Fertilizers said in a statement.
The DoP is implementing three PLI schemes — PLI scheme for Bulk Drugs (Rs 6,940 crore), PLI scheme for Medical Devices (Rs 3,420 crore) and PLI scheme for Pharmaceuticals (Rs 15,000 crore) to promote the domestic manufacturing. PLI Scheme for Bulk Drugs was approved by the Cabinet in 2020.
Under two rounds of inviting applications, a total of 49 projects have been approved for 33 critical APIs with a committed investment of Rs 3,685 crore.
(Edited by : Shloka Badkar)
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
Lok Sabha Election 2024: Phase 5 voting concludes with over 57% voter turnout, experts weigh in on key battles
May 20, 2024 11:07 PM
BJP holds meeting in Delhi as polling underway for 5th phase
May 20, 2024 4:21 PM
UP Police arrests man after viral videos shows him voting multiple times
May 20, 2024 2:18 PM